These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2060128)

  • 41. Antimalarial activity of cyclosporins A, C and D.
    Uadia PO; Ezeamuzie IC; Ladan MJ; Gerrets R
    Afr J Med Med Sci; 1994 Mar; 23(1):47-51. PubMed ID: 7839946
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New cyclosporine derivative SDZ IMM 125: in vitro and in vivo pharmacologic effects and toxicologic evaluation.
    Hiestand PC; Gräber M; Hurtenbach U; Herrmann P; Cammisuli S; Richardson BP; Eberle MK; Donatsch P; Ryffel B; Borel JF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):691-2. PubMed ID: 8438439
    [No Abstract]   [Full Text] [Related]  

  • 44. In vitro comparative study on nephrotoxicity of cyclosporine A, its metabolites M1, M17, M21, and its analogues cyclosporines C and D in suspensions of rabbit renal cortical cells.
    Sadeg N; Pham-Huy C; Martin C; Warnet JM; Claude JR
    Drug Chem Toxicol; 1994; 17(2):93-111. PubMed ID: 7914868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G.
    Hoyt EG; Hagberg RC; Billingham ME; Baldwin JC; Jamieson SW
    J Heart Transplant; 1988; 7(2):111-7. PubMed ID: 3284981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cyclosporin A on a kidney epithelial cell line (LLC-PK1).
    Becker GM; Gandolfi AJ; Nagle RB
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):277-80. PubMed ID: 3602589
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effect of cyclosporin A and G on weight gain of primates during the pubertal growth period.
    Harjula A; Baldwin JC; Hoffman AR; Billingham ME; Shumway NE
    J Heart Transplant; 1987; 6(4):222-7. PubMed ID: 3668706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity.
    Quesniaux VF; Schreier MH; Wenger RM; Hiestand PC; Harding MW; Van Regenmortel MH
    Eur J Immunol; 1987 Sep; 17(9):1359-65. PubMed ID: 3308488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
    Sadeg N; Pham-Huy C; Rucay P; Righenzi S; Halle-Pannenko O; Claude JR; Bismuth H; Duc HT
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):163-77. PubMed ID: 8349948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of cyclosporine and cyclosporine metabolites in experimental small intestinal transplantation.
    Kim PC; Cohen Z; Wong PY; Cole E; Cullen J; Skorecki K; Cheung F; Fung LS; Craig M; Levy GA
    Transplantation; 1990 Jun; 49(6):1043-50. PubMed ID: 2360247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract]   [Full Text] [Related]  

  • 53. Evidence that the immunosuppressive effects of FK506 and cyclosporine are identical.
    Johansson A; Möller E
    Transplantation; 1990 Dec; 50(6):1001-7. PubMed ID: 1701570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclosporine: immunology, toxicity and pharmacology in experimental animals.
    Thomson AW; Whiting PH; Simpson JG
    Agents Actions; 1984 Oct; 15(3-4):306-27. PubMed ID: 6395677
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of cyclosporine-A and cyclosporine-G on ADP-stimulated aggregation of human platelets.
    Markell MS; Fernandez J; Naik UP; Ehrlich Y; Kornecki E
    Ann N Y Acad Sci; 1993 Nov; 696():404-7. PubMed ID: 8109851
    [No Abstract]   [Full Text] [Related]  

  • 56. Modification of experimental nephrotoxicity with fish oil as the vehicle for cyclosporine.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplantation; 1987 Feb; 43(2):271-4. PubMed ID: 3810835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacology and pharmacokinetics of cyclosporine.
    Freeman DJ
    Clin Biochem; 1991 Feb; 24(1):9-14. PubMed ID: 2060139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic Pathway of Cyclosporine A and Its Correlation with Nephrotoxicity.
    Wu Q; Kuca K
    Curr Drug Metab; 2019; 20(2):84-90. PubMed ID: 30378493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The cyclosporins inhibit lymphocyte activation at more than one site.
    Gelfand EW; Cheung RK; Mills GB
    J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.